Gastroesophageal Reflux Disease
Conditions
Interventions
Proton pump inhibitor of the standard dose (+) mosapride(15 mg / day for 4 weeks)
Proton pump inhibitor of the standard dose(+) Placebo(+)
Sponsors
Department of Gastroenterology , Shimane University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: In GERD patients with sleeping disorders, who Proton pump inhibitor of standard doses of (PPI) during treatment
Exclusion criteria
Exclusion criteria: Example that started the oral sleep-inducing agent within two weeks. Patients with serious underlying disease that affect sleep. Examples are allergic to mosapride. Examples of oral administration of the drug combination and attention mosapride. Examples of oral medicine in the related to gastrointestinal motor function. Patients with psychiatric disorders. Examples of surgical procedures after the gastroesophageal. Example pregnant or nursing. Example not be obtained consent. Example the attending physician is deemed inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre-dose, two weeks after dosing, four weeks after dosing, have them listed Japanese translation of the Quality of Life in Reflux and Dyspepsia (QOLRAD-J), Epworth Sleepness Scale (ESS), Pittsburgh Sleep Quality Index in (PSQI), respectively to evaluate. | — |
Countries
Japan
Contacts
Public ContactEiko Okimoto
Shimane University School of Medicine Department of Gastroenterolog
Outcome results
None listed